4,7,10,13,16,19-docosahexaenoic acid dopamine conjugate,
DHA-DA conjugate,
N-(2-(3,4-dihydroxyphenyl)ethyl)-4,7,10,13,16,19-docosahexaenamide,
NMI 8739,
NMI-8739,
Nmi 8739,
129024-87-9,
Dha-DA conjugate,
Nmi-8739,
AC1O602R,
CHEMBL343736,
SCHEMBL11888439,
4,7,10,13,16,19-Docosahexaenoic acid dopamine conjugate,
N-(2-(3,4-Dihydroxyphenyl)ethyl)-4,7,10,13,16,19-docosahexaenamide,
NCGC00161234-02,
HY-101540,
CS-0021682,
(4Z,7Z,10Z,13Z,16Z,19Z)-N-(3,4-Dihydroxyphenethyl)-4,7,10,13,16,19-docosahexenamide,
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]docosa-4,7,10,13,16,19-hexaenamide,
CID6443994,